Treatment of atherosclerosis obliterans with pyridinolcarbamate.
D000328:Adult; D000368:Aged; D001162:Arteriosclerosis Obliterans / Q000188:drug therapy*; D002219:Carbamates / Q000627:therapeutic use*; D003490:Cyanosis / Q000188:drug therapy; D005260:Female; D005263:Femoral Artery / Q000000981:diagnostic imaging; D005500:Follow-Up Studies; D005528:Foot; D006801:Humans; D007383:Intermittent Claudication / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D010146:Pain / Q000188:drug therapy; D010292:Paresthesia / Q000188:drug therapy; D010991:Plethysmography; D011674:Pulse / Q000187:drug effects; D011725:Pyridines / Q000627:therapeutic use; D011859:Radiography; D014456:Ulcer / Q000188:drug therapy
D002219:Carbamates; D011725:Pyridines